2023 Form 5500 filing — Horizon Therapeutics Usa, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241008095648NAL0034308306001) for Horizon Therapeutics Usa, Inc. 401(K) Plan, reported by Horizon Therapeutics Usa, Inc. under EIN 56-2523161 and plan number 001. It reports 2,297 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20241008095648NAL0034308306001
Filing year
2023
Form type
2
Plan sponsor
Horizon Therapeutics Usa, Inc.
EIN
56-2523161
Plan number
001
Location
Deerfield, IL
Participants
2,297
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$294,515,174
Total liabilities (EOY)
$0
Net assets (EOY)
$294,515,174
Employer contributions
$26,096,159
Participant contributions
$29,097,230
Total income / additions
$104,487,106
Benefits paid
$24,044,333
Administrative expenses
-$25,900
Total expenses
$24,029,179
Net increase / (decrease)
$80,457,927
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Strategic Advisors, Inc.ADVISOR$82,702not reported in the loaded dataset
Fidelity Investments InstitutionalRECORDKEEPER-$108,602$0

Related Form 5500 pages